← Back

Third Rock Ventures VII

Third Rock Ventures

vc$1.1BCo-investsLeads rounds

◆ Fund Size

$1.1B

◆ Check Size

$1.5M→$50.0M

◆ Location

United States

◆ Portfolio

7 companies

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Investment Thesis

Third Rock Ventures invests where major scientific advances can be translated into transformative medicines and healthcare products, especially in areas with high unmet medical need. Its approach is to actively participate in company creation rather than passively fund existing startups, pairing breakthrough science with operational support, strategy, leadership recruiting, and clinical-development expertise to increase the odds of building category-defining life sciences companies.

◆ About Third Rock Ventures

Third Rock Ventures is a healthcare and life sciences venture firm focused on advancing disruptive science and medicine. It takes a hands-on company-formation approach, often working with scientific founders and experts from the earliest stages to build new biotech and health-focused companies.

◆ Sectors

Artificial Intelligence and Machine LearningAutoimmune DiseaseCancerCardiovascular DiseaseCell and Gene TherapyDevice and Therapeutic TechnologyDiagnosticGastrointestinal DisorderHearing DisordersInfectious DiseasesInflammatory DiseasesMetabolic DisorderNeurodegenerative DiseaseNeurologic and Psychiatric DiseasesOphthalmologyRare Genetic and Orphan DiseasesRenal DisorderRespiratory DiseaseUrology

◆ Stages

pre-seedseedseries-aseries-b

◆ Geography Focus

East CoastWest Coast

◆ Team

NameTitleRoleLinks
Danielle AbdelahadVice President, Head of PeopleSeniorin
Gabriella WilliamsSenior Director, Management Company ControllerSeniorin
Bob TepperCo-founder—
Kevin StarrCo-founder—
Lisa PurcellEntrepreneur-in-ResidenceEntrepreneur-in-Residencein
Mark LevinCo-founder—

◆ Notable Investments

ModernaSage TherapeuticsRapt TherapeuticsGenerate:BiomedicinesRelay TherapeuticsCandid TherapeuticsTango TherapeuticsAzalea TherapeuticsMarea TherapeuticsSeaport TherapeuticsMerida BiosciencesARTBIOMaze TherapeuticsTrace NeuroscienceGlobal Blood TherapeuticsBlueprint MedicinesBluebird BioEditas Medicine

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Third Rock Ventures VII invest in?

Third Rock Ventures VII invests in Artificial Intelligence and Machine Learning, Autoimmune Disease, Cancer, Cardiovascular Disease, Cell and Gene Therapy, Device and Therapeutic Technology, Diagnostic, Gastrointestinal Disorder, Hearing Disorders, Infectious Diseases, Inflammatory Diseases, Metabolic Disorder, Neurodegenerative Disease, Neurologic and Psychiatric Diseases, Ophthalmology, Rare Genetic and Orphan Diseases, Renal Disorder, Respiratory Disease and Urology at the pre-seed, seed, series-a and series-b stages.

Which geographies does Third Rock Ventures VII focus on?

Third Rock Ventures VII focuses on East Coast and West Coast, and is headquartered in United States.

What is Third Rock Ventures VII's typical check size?

Third Rock Ventures VII typically writes checks of $1.5M to $50M.